Axa
NTNX icon

Axa’s Nutanix NTNX Stock Holding History

Axa’s Portfolio NTNX Stock Details NTNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-449,574
Closed -$34.4M – 716
2025
Q2 		$34.4M Buy
449,574
+388,912
+641% +$28M 0.1% 185
2025
Q1 		$4.23M Buy
60,662
+50,978
+526% +$3.53M 0.01% 585
2024
Q4 		$592K Sell
9,684
-7,890
-45% -$516K ﹤0.01% 928
2024
Q3 		$1.04M Sell
17,574
-817
-4% -$44.9K ﹤0.01% 873
2024
Q2 		$1.05M Buy
+18,391
New +$1.13M ﹤0.01% 870
2022
Q4 		– Sell
-55,100
Closed -$1.15M – 1198
2022
Q3 		$1.15M Buy
+55,100
New +$1.01M ﹤0.01% 841
2021
Q1 		– Sell
-103,800
Closed -$3.31M – 1295
2020
Q4 		$3.31M Sell
103,800
-52,800
-34% -$1.43M 0.01% 775
2020
Q3 		$3.47M Buy
156,600
+38,000
+32% +$869K 0.01% 720
2020
Q2 		$2.81M Buy
118,600
+97,000
+449% +$2.01M 0.01% 755
2020
Q1 		$341K Buy
+21,600
New +$607K ﹤0.01% 1030

Other funds holding NTNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Axa's NTNX Position: Q3 2025 in Review

Axa sold out of Nutanix (NTNX) in Q3 2025, closing a stake of 449,574 shares — an estimated $34.4M sold.

Axa first reported a position in NTNX in Q1 2020 and held it in 10 quarters. The position peaked at $34.4M in Q2 2025. 621 funds tracked by Wall St. Rank hold NTNX as of Q3 2025.

  • Axa reported no remaining Nutanix position as of Q3 2025 after selling out during the quarter.
  • Axa sold 449,574 Nutanix shares in Q3 2025, an estimated $34.4M.
  • Axa first reported a position in Nutanix in Q1 2020 and held it in 10 quarters.
  • Axa's Nutanix position peaked at $34.4M in Q2 2025.
  • 621 funds tracked by Wall St. Rank held Nutanix as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.